Key Highlights

  • Third-quarter net Earnings at Aflac (NYSE:AFL) landed at USD 303 million, which is USD 0.61 a diluted share, an 81.5% decline from USD 1.6 billion, or USD 3.08 a share a year earlier, with USD 1.1 billion of net Investment losses weighing on the figure.
  • Adjusted earnings came to USD 1.21 billion, down 8.5%, and adjusted EPS slipped 2.4% to USD 2.43, a figure that includes USD 453 million of reserve remeasurement gains.
  • On a pretax adjusted basis, the U.S. unit's profit grew 31.5% to USD 493 million, whereas Japan's unit slipped 21.0% in dollar terms to USD 961 million.
  • Shareholders received USD 1.1 billion during the quarter: USD 804 million via Buybacks and USD 305 million as dividends. A fourth-quarter payout of USD 0.61 a share was also declared.

Repositioning Charges Account for Most of the Earnings Drop

Aflac (NYSE:AFL) released its third-quarter numbers on November 4, 2026. Revenue fell 31.0% to USD 3.27 billion, and management points to realized losses from reshaping the investment book as the chief reason net earnings dropped. Investment losses reached USD 1.1 billion, or USD 2.15 a share: USD 842 million tied to sales and redemptions, USD 146 million tied to certain Derivatives and currency moves, and USD 102 million of anticipated Credit losses. A USD 51 million valuation allowance on tax loss carryforwards took another USD 0.10 a share. Return on average equity, annualized, was 4.1%. Because adjusted earnings strip out these investment items, the two measures tell different stories.

Japan Margin Narrows While the U.S. Business Gains Ground

Japan's pretax adjusted profit dropped 15.2% in yen terms to 152 billion yen. Lower reserve remeasurement gains from revisited actuarial assumptions and heavier benefit costs explain much of it, and the profit margin narrowed to 44.4% from 52.2%. Net earned premiums in yen declined 2.0%, while sales fell 4.0% after a strong prior-year run for the Miraito cancer product. Across the Pacific, net earned premiums grew 3.3% to USD 1.54 billion and sales rose 3.5% to USD 403 million, with the margin improving to 27.7% from 21.7% on higher remeasurement gains. The yen averaged 158.49 per dollar, a 6.8% Depreciation that cost USD 0.03 a share in adjusted earnings. Japan also transferred around 500 billion yen of cancer reserves to Aflac Re Bermuda.

A 44-Year Dividend Record and the Capital Return Ledger

A USD 0.61 fourth-quarter payout per share goes out December 1, 2026, to those registered on November 18, continuing 44 years of consecutive dividend raises. Equity stood at USD 29.3 billion, or USD 59.08 a share, while adjusted Book Value excluding accumulated other comprehensive income reached USD 54.21 a share. Stripping out currency remeasurement, adjusted book value declined to USD 40.73 from USD 43.52, and on that footing annualized adjusted ROE was 23.7%. Nine-month adjusted EPS held at USD 5.92, or USD 6.02 without currency effects, a 1.7% increase. An Earnings Call is set for November 5, 2026, and it will add context on the adjusted figures.

Where Things Stand

Yes, largely. The portfolio reshuffle, rather than the insurance business, drove the drop. Aflac (NYSE:AFL) held adjusted EPS within 2.4% of last year even as net earnings fell 81.5%, and the U.S. segment improved while Japan margins narrowed. Adjusted results rely on USD 453 million of reserve remeasurement gains, which hinge on actuarial assumptions, so the Quality of Earnings warrants scrutiny. Next markers are the November 5 call, the December 1 payment, yen moves and further portfolio changes.